MEENU SINGHAL
Allopathic & Osteopathic Physicians|Family Medicine EVANS, GA NPI 1851456776
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine GA Otsuka America Pharmaceutical, Inc. All categories
General Payments — all program years on this page
$870.73
- Category: General Payments
- Program years: PY2018–2024
- Record count: 31
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $270.82 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $270.82 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $124.37 | 1 |
| Abbott Laboratories | $38.44 | 2 |
| ABBVIE INC. | $27.80 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $25.48 | 1 |
| Lilly USA, LLC | $19.49 | 1 |
| DEXCOM, INC. | $18.37 | 1 |
| Novo Nordisk AS | $16.87 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1092398184 | Boston Scientific Corporation | $25.48 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096899300 | Novo Nordisk Inc | $16.87 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106113371 | ABBVIE INC. | $14.58 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106113373 | ABBVIE INC. | $13.22 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118984074 | Otsuka America Pharmaceutical, Inc. | $124.37 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125303901 | Abbott Laboratories | $21.63 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125303903 | Abbott Laboratories | $16.81 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135187235 | Lilly USA, LLC | $19.49 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153321328 | Dexcom, Inc. | $18.37 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.